Food and Drug Administration (FDA) has created a new web page to help answer questions regarding the Memorandum of Understanding (MOU) Addressing Certain Distributions of Compounded Human Drug Products from boards of pharmacy and other state agencies. The web page will continue to be updated by FDA as additional questions on the MOU are received. FDA worked with NABP to develop a standard MOU for use by the state boards of pharmacy to assist with their compliance of section 503A(b)(3)(B)(i) of the Federal Food, Drug, and Cosmetic Act. As part of the MOU, boards must identify pharmacies that are compounding human drug products and distributing inordinate amounts of such products interstate and report those pharmacies to FDA. Additional resources and information on the FDA MOU and the Compounding Pharmacy Information Sharing Project can be found through the Members section of the NABP website.